Clinical trials
Phase 1/2 Lymphoma, Follicular trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Unknown status | 7 |
| Active, not recruiting | 2 |
| Completed | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 3 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 3 |
| BeiGene | 2 |
| Essen Biotech | 2 |
| AstraZeneca | 1 |
| BeOne Medicines | 1 |
| Beijing Mabworks Biotech Co., Ltd. | 1 |
| BioNova Pharmaceuticals (Shanghai) LTD. | 1 |
| Guangzhou Lupeng Pharmaceutical Company LTD. | 1 |
| Haihe Biopharma Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 22 |
| Lymphoma, Large B-Cell, Diffuse | 16 |
| Lymphoma, Mantle-Cell | 15 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 13 |
| Lymphoma, Non-Hodgkin | 6 |
| Lymphoma, B-Cell, Marginal Zone | 5 |
| Hematologic Neoplasms | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Leukemia, Prolymphocytic | 3 |
| Leukemia, Prolymphocytic, B-Cell | 3 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.